• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Varian Medical Systems

Varian Medical Systems

Varian Medical Systems Inc VAR 4 Star

Last Price$82.47Day Change (%)0.79%
Open Price$81.33Day Change ($)0.65
Day Range81.28–82.5352-Week Range76.73–96.67

As of Fri 8/28/2015 5:57:00 PM | USD

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. China's Woes Echo in U.S. Earnings

    China's Woes Echo in U.S. Earnings

  2. Greece’s Darkest Hour Before Its Dawn

    Varian Medical Systems' VAR third-quarter results were in line with our expectations, and we are leaving our fair value estimate unchanged. Overall, revenue increased 7%, and net orders rose 13%, bringing the company's backlog at quarter-end to $1.6 billion. Revenue for the oncology system segment ...

  3. Research and Markets: Global External Beam Radiation Therapy Devices, Technologies and Applications Market 2015-2019 - North America Led the Market With a Share of 38.4% in 2014

    Research and Markets: Global External Beam Radiation Therapy Devices, Technologies and Applications Market 2015-2019 - North America Led the Market With a Share of 38.4% in 2014

  4. Safe Stocks for Worried Investors

    The stocks mentioned in this article be holdings in the managed portfolios of Validea Capital Management, a separate asset management firm founded by Validea.com founder John Reese. Validea Capital Management, which an SEC registered investment advisory firm and a separate company from Validea.com, ...

  5. The Middle Ground

    The stocks mentioned in this article be holdings in the managed portfolios of Validea Capital Management, a separate asset management firm founded by Validea.com founder John Reese. Validea Capital Management, which an SEC registered investment advisory firm and a separate company from Validea.com, uses, in part, the strategies discussed in this article to select stocks for its clients.

  6. Research Roundup: Foreign Diversification, Social Comparisons and Consumer Identity

    Varian Medical's VAR third-quarter fiscal 2006 results fall right in line with the seasonal patterns we expected from our current near-term modeling assumptions. The oncology group notched 14% growth, and customer demand continues to reflect a shift toward Varian's next-generation IGRT technology, ...

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.